For example, two glioma patients with a BRCA2 LoF GV also had skin tumors, and both glioma patients with a PMS2 missense GV had a syn- or metachronous tumor of the skin or the breast (Fig. 3a, Fig. 3c, Supplementary Fig. 3 online resource). This evidence concerns the gene PMS2 and central nervous system cancer.